Intellia Therapeutics Aktie
11,48
EUR
-0,36
EUR
-3,04
%
13,51
USD
+0,01
USD
+0,07
%
Werbung
Intellia Therapeutics Aktie Analyse
| 15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung